TWD
SAGE

True Wealth Design’s Sage Therapeutics SAGE Stock Holding History

True Wealth Design’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,191
Closed -$10.9K – 2861
2025
Q2 		$10.9K Buy
1,191
+410
+52% +$3.02K ﹤0.01% 548
2025
Q1 		$6.21K Buy
781
+745
+2,069% +$5.46K ﹤0.01% 612
2024
Q4 		$196 Sell
36
-157
-81% -$960 ﹤0.01% 1227
2024
Q3 		$1.39K Buy
+193
New +$1.77K ﹤0.01% 886

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

True Wealth Design's SAGE Position: Q3 2025 in Review

True Wealth Design sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,191 shares — an estimated $10.9K sold.

True Wealth Design first reported a position in SAGE in Q3 2024 and held it in 4 quarters. The position peaked at $10.9K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • True Wealth Design reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 1,191 Sage Therapeutics shares in Q3 2025, an estimated $10.9K.
  • True Wealth Design first reported a position in Sage Therapeutics in Q3 2024 and held it in 4 quarters.
  • True Wealth Design's Sage Therapeutics position peaked at $10.9K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.